Predictors of mortality among inpatients with COVID-19 infection in a tertiary referral center in the Philippines

被引:3
作者
Malundo, Anna Flor G. [1 ]
Abad, Cybele Lara R. [2 ]
Salamat, Maria Sonia S. [2 ]
Sandejas, Joanne Carmela M. [2 ]
Poblete, Jonnel B. [2 ,3 ]
Planta, Jose Eladio G. [2 ]
Morales, Shayne Julieane L. [2 ]
Gabunada, Ron Rafael W. [2 ]
Evasan, Agnes Lorrainne M. [2 ]
Canal, Johanna Patricia A. [4 ]
Santos, Julian A. [4 ]
Manto, Jeffrey T. [4 ]
Mercado, Maria Elizabeth P. [5 ]
Rojo, Raniv D. [6 ]
Ornos, Eric David B. [6 ]
Alejandria, Marissa M. [2 ]
机构
[1] Univ Philippines Manila, Philippine Gen Hosp, Dept Med, Div Infect Dis, Taft Ave, Manila, Philippines
[2] Univ Philippines, Div Infect Dis, Philippine Gen Hosp, Manila, Philippines
[3] Univ Philippines, Philippine Gen Hosp, Dept Med, Manila, Philippines
[4] Univ Philippines, Philippine Gen Hosp, Dept Radiol, Manila, Philippines
[5] Univ St Tomas, Fac Med & Surg, Dept Clin Epidemiol, Manila, Philippines
[6] Univ Philippines, Coll Med, Manila, Philippines
来源
IJID REGIONS | 2022年 / 4卷
关键词
COVID-19; Philippines; epidemiology; mortality;
D O I
10.1016/j.ijregi.2022.07.009
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: The aim of this study was to determine the predictors of mortality and describe laboratory trends among adults with confirmed COVID-19.Methods: The medical records of adult patients admitted to a referral hospital with COVID-19 were retrospectively reviewed. Demographic and clinical characteristics, and laboratory parameters, were compared between survivors and non-survivors. Predictors of mortality were determined by multivariate analysis. Mean laboratory values were plotted across illness duration.Results: Of 1215 patients, 203 (16.7%) had mild, 488 (40.2%) moderate, 183 (15.1%) severe, and 341 (28.1%) critical COVID-19 on admission. In-hospital mortality was 18.2% (0% mild, 6.1% moderate, 15.8% severe, 47.5% critical). Predictors of mortality were age >= 60 years, COPD, qSOFA score >= 2, WBC > 10 x 10(9)/L, absolute lymphocyte count < 1000, neutrophil >= 70%, PaO2/FiO(2) ratio <= 200, eGFR < 90 mL/min/1.73 m(2), LDH > 600 U/L, and CRP > 12 mg/L. Non-survivors exhibited an increase in LDH and decreases in PaO2/FiO(2) ratio and eGFR during the 2nd-3rd week of illness.Conclusion: The overall mortality rate was high. Predictors of mortality were similar to those of other reports globally. Marked inflammation and worsening pulmonary and renal function were evident among non-survivors by the 2nd-3rd week of illness.
引用
收藏
页码:134 / 142
页数:9
相关论文
共 35 条
  • [1] Early experience with COVID-19 patients in a private tertiary hospital in the Philippines: Implications on surge capacity, healthcare systems response, and clinical care
    Abad, Cybele L.
    Lansang, Mary Ann D.
    Cordero, Cynthia P.
    Viray, Ethel Dominique E.
    Tiangco, Beatrice J.
    Bello, Jia An G.
    Francisco, Jan Jorge M.
    Buensalido, Marja B.
    Tayzon, Maria Fe R.
    Henson, Karl Evans R.
    Berba, Regina P.
    Paz-Pacheco, Elizabeth
    Saniel, Mediadora C.
    [J]. CLINICAL EPIDEMIOLOGY AND GLOBAL HEALTH, 2021, 10
  • [2] Incidence and risk factors of acute kidney injury in COVID-19 patients with and without acute respiratory distress syndrome (ARDS) during the first wave of COVID-19: a systematic review and Meta-Analysis
    Alenezi, Faraj K.
    Almeshari, Mohammed A.
    Mahida, Rahul
    Bangash, Mansoor N.
    Thickett, David R.
    Patel, Jaimin M.
    [J]. RENAL FAILURE, 2021, 43 (01) : 1621 - 1633
  • [3] Bajo, 2022, GMA News Online
  • [4] Balagtas Aie, 2021, TIME
  • [5] Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients
    Bellan, Mattia
    Patti, Giuseppe
    Hayden, Eyal
    Azzolina, Danila
    Pirisi, Mario
    Acquaviva, Antonio
    Aimaretti, Gianluca
    Aluffi Valletti, Paolo
    Angilletta, Roberto
    Arioli, Roberto
    Avanzi, Gian Carlo
    Avino, Gianluca
    Balbo, Piero Emilio
    Baldon, Giulia
    Baorda, Francesca
    Barbero, Emanuela
    Baricich, Alessio
    Barini, Michela
    Barone-Adesi, Francesco
    Battistini, Sofia
    Beltrame, Michela
    Bertoli, Matteo
    Bertolin, Stephanie
    Bertolotti, Marinella
    Betti, Marta
    Bobbio, Flavio
    Boffano, Paolo
    Boglione, Lucio
    Borre, Silvio
    Brucoli, Matteo
    Calzaducca, Elisa
    Cammarata, Edoardo
    Cantaluppi, Vincenzo
    Cantello, Roberto
    Capponi, Andrea
    Carriero, Alessandro
    Casciaro, Francesco Giuseppe
    Castello, Luigi Mario
    Ceruti, Federico
    Chichino, Guido
    Chirico, Emilio
    Cisari, Carlo
    Cittone, Micol Giulia
    Colombo, Crizia
    Comi, Cristoforo
    Croce, Eleonora
    Daffara, Tommaso
    Danna, Pietro
    Della Corte, Francesco
    De Vecchi, Simona
    [J]. SCIENTIFIC REPORTS, 2020, 10 (01)
  • [6] Higher mortality of COVID-19 in males: sex differences in immune response and cardiovascular comorbidities
    Bienvenu, Laura A.
    Noonan, Jonathan
    Wang, Xiaowei
    Peter, Karlheinz
    [J]. CARDIOVASCULAR RESEARCH, 2020, 116 (14) : 2197 - 2206
  • [7] Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study
    Challen, Robert
    Brooks-Pollock, Ellen
    Read, Jonathan M.
    Dyson, Louise
    Tsaneva-Atanasova, Krasimira
    Danon, Leon
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2021, 372
  • [8] The contributory role of lymphocyte subsets, pathophysiology of lymphopenia and its implication as prognostic and therapeutic opportunity in COVID-19
    Delshad, Mahda
    Tavakolinia, Naeimeh
    Pourbagheri-Sigaroodi, Atieh
    Safaroghli-Azar, Ava
    Bagheri, Nader
    Bashash, Davood
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 95
  • [9] Department of Health, 2022, COVID-19 Tracker Philippines
  • [10] COVID-19 outcomes of 10,881 patients: retrospective study of neurological symptoms and associated manifestations (Philippine CORONA Study)
    Espiritu, Adrian I.
    Sy, Marie Charmaine C.
    Anlacan, Veeda Michelle M.
    Jamora, Roland Dominic G.
    [J]. JOURNAL OF NEURAL TRANSMISSION, 2021, 128 (11) : 1687 - 1703